stoxline Quote Chart Rank Option Currency Glossary
  
HeartBeam, Inc. (BEAT)
1.34  -0.13 (-8.84%)    12-07 15:59
Open: 1.5
High: 1.5
Volume: 38,707
  
Pre. Close: 1.47
Low: 1.34
Market Cap: 35(M)
Technical analysis
2023-12-07 4:19:14 PM
Short term     
Mid term     
Targets 6-month :  1.75 1-year :  2.04
Resists First :  1.5 Second :  1.75
Pivot price 1.39
Supports First :  1.3 Second :  1.19
MAs MA(5) :  1.45 MA(20) :  1.36
MA(100) :  1.96 MA(250) :  2.67
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  74.7 D(3) :  85.6
RSI RSI(14): 47.1
52-week High :  6 Low :  1.11
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ BEAT ] has closed above bottom band by 45.4%. Bollinger Bands are 61.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.5 - 1.51 1.51 - 1.51
Low: 1.41 - 1.42 1.42 - 1.43
Close: 1.46 - 1.47 1.47 - 1.48
Company Description

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

Headline News

Wed, 15 Nov 2023
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2023 Earnings Call Transcript - Yahoo Finance

Tue, 14 Nov 2023
HeartBeam Reports Third Quarter 2023 Financial Results - Business Wire

Tue, 07 Nov 2023
HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex ... - Business Wire

Tue, 26 Sep 2023
HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team - Business Wire

Mon, 04 Sep 2023
Insiders of HeartBeam Getting Good Value On Their US$2.9m Investment - Simply Wall St

Tue, 15 Aug 2023
HeartBeam, Inc. (NASDAQ:BEAT) Q2 2023 Earnings Call Transcript - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Health Information Services
Shares Out 26 (M)
Shares Float 19 (M)
Held by Insiders 25.6 (%)
Held by Institutions 2.8 (%)
Shares Short 50 (K)
Shares Short P.Month 56 (K)
Stock Financials
EPS -1.04
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.7
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -71 %
Return on Equity (ttm) -118.8 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow -12 (M)
Levered Free Cash Flow -7 (M)
Stock Valuations
PE Ratio -1.33
PEG Ratio 0
Price to Book value 1.94
Price to Sales 0
Price to Cash Flow -2.99
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android